Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06055322 · ClinicalTrials.gov registry record · NA

Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD

A NA study of Depression and Inflammation, sponsored by Texas Tech University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06055322 is a NA study of Depression and Inflammation that is actively recruiting participants, run by Texas Tech University. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06055322, a NA study of Depression and Inflammation, is actively recruiting participants, sponsored by Texas Tech University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) to reduce suicidality. By adapting this modality, the investigators will provide a scalable intervention tailored for this high-risk population, maximizing the public health impact and improving suicide prevention.

Interventions

  • BEHAVIORAL Adapted Dialectical Behavior Therapy

Study Locations (1)

Texas

  • Garrison Institute on Aging - Lubbock

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-01-07
Est. Completion 2026-08-31
Phase NA

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT06055322

The ClinicalTrials.gov registry entry for NCT06055322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Adapted Dialectical Behavior Therapy is the first listed.

NCT06055322 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06055322 about?

NCT06055322 is a clinical study titled "Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD". This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) to reduce suicidality. By adapting this modality, the investi...

What is the current status of trial NCT06055322?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-07. Estimated completion is 2026-08-31.

What conditions does trial NCT06055322 study?

This clinical trial studies the following conditions: Depression, Inflammation, Suicide, Caregiver Burden, Physical Health.

What interventions are being tested in trial NCT06055322?

The interventions under investigation include: Adapted Dialectical Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06055322?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06055322 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.